<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
VRDN
Viridian Therapeutics
$
()


  • Viridian Therapeutics CEO buys $499.3K in common stock

    9/30/2024 - 20:19pm
  • Viridian Therapeutics price target raised by $5 at BTIG, here's why

    9/26/2024 - 07:10am
  • Largest borrow rate increases among liquid names

    9/25/2024 - 08:45am
  • Largest borrow rate increases among liquid names

    9/19/2024 - 08:45am
  • Viridian Therapeutics price target raised by $9 at RBC Capital, here's why

    9/13/2024 - 07:52am
  • Viridian Therapeutics 10.67M share Secondary priced at $18.75

    9/11/2024 - 23:53pm
  • Closing Bell Movers: Dave & Busters jumps 10% after earnings beat

    9/10/2024 - 17:22pm
  • What You Missed On Wall Street On Tuesday

    9/10/2024 - 16:12pm
  • Viridian Therapeutics announces $150M common stock and preferred stock offering

    9/10/2024 - 16:03pm
  • Viridian Therapeutics price target raised by $7 at Stifel, here's why

    9/10/2024 - 13:20pm
  • Oracle reports Q1 beat, EU says Apple must pay: Morning Buzz

    9/10/2024 - 12:05pm
  • Viridian TED data adds new overhang to Amgen's Tepezza growth, says Barclays

    9/10/2024 - 11:56am
  • Viridian poised to take share in TED market, says H.C. Wainwright

    9/10/2024 - 11:21am
  • Viridian Therapeutics price target raised by $10 at BTIG, here's why

    9/10/2024 - 11:08am
  • Morning Movers: Viridian surges following THRIVE trial data readout

    9/10/2024 - 09:00am
dynamic_feed Breaking News